IS RECEPTOR ACTIVATION INVOLVED IN THE MECHANISM BY WHICH (+)-FENFLURAMINE AND (+)-NORFENFLURAMINE DEPLETE 5-HYDROXYTRYPTAMINE IN THE RAT BRAIN?
Open Access
- 1 March 1982
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 75 (3) , 525-530
- https://doi.org/10.1111/j.1476-5381.1982.tb09169.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Evidence of the existence of two different intraneuronal pools from which pharmacological agents can release serotoninNeurochemistry International, 1981
- Localization of fenfluramine and reserpine in brain regions of rats with extensive degeneration of 5-hydroxytryptaminergic neuronsJournal of Pharmacy and Pharmacology, 1980
- A RAPID AND SIMPLE METHOD FOR THE DETERMINATION OF PICOGRAM LEVELS OF SEROTONIN IN BRAIN TISSUE USING LIQUID CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTIONJournal of Neurochemistry, 1979
- Biochemical pharmacology of the anorectic drug fenfluramine: a reviewCurrent Medical Research and Opinion, 1979
- Further evidence that methergoline is a central 5-hydroxytryptamine receptor blocking agentNeuroscience Letters, 1978
- FENFLURAMINE AND BRAIN SEROTONINAnnals of the New York Academy of Sciences, 1978
- Metergoline as a selective 5-hydroxytryptamine antagonist in the cerebral cortexCanadian Journal of Physiology and Pharmacology, 1977
- Effect of ergot drugs on central 5-hydroxytryptamine neurons: Evidence for 5-hydroxytryptamine release or 5-hydroxytryptamine receptor stimulationEuropean Journal of Pharmacology, 1975
- Effect of thymoleptics on fenfluramine-induced depletion of brain serotonin in ratsEuropean Journal of Pharmacology, 1973
- Amphetamine analogues and brain aminesLife Sciences, 1972